Expert Chaslau Koniukh
  • Companies
  • Global investment
  • Investors
  • Terminology
  • Economy
  • Stock Market
  • World exchanges
  • Tech and Marketing
French vaccine manufacturer Valneva
Global investment

Pfizer acquired shares in French company Valneva

07.09.2022
2 min read

Pfizer signs deal with vaccine manufacturer Valneva

American pharmaceutical corporation Pfizer made a deal with Valneva. According to the agreement, Pfizer acquires 8.1% of the shares of the French vaccine manufacturer, the total investment will amount to 95.25 million dollars.
The main purpose of the American corporation is to develop and release to the market a vaccine against Lyme disease, which is exactly what Valneva does.
According to a statement from Pfizer representatives, the companies plan to combine their experience and expertise to create an effective vaccine against the disease. This is quite a brave step, considering that science has not yet created a cure for Lyme disease, however, the world is in dire need of it. The disease is a bacterial infection, contracted through a tick bite.
According to the terms of the deal, Pfizer will pay about 9.5 euros for each Valneva share. For this purpose, the American corporation will use money from the reserved capital. It should be noted that the value of Valneva shares since the beginning of the current year decreased by 75.3%. Pfizer’s quotations also fell. Despite the fact that the corporation produces a popular vaccine against COVID-19, its shares fell by 21% in 2022.ValnevaThe manufacturers plan to start clinical trials of a new vaccine against Lyme disease by the end of the year, now the development has reached the final stage. According to Pfizer representatives, the vaccine created by the company is the only one of its kind, other companies have not announced the creation of such a drug.
Pfizer and Valneva began cooperating on vaccine development back in 2020. As a result of the deal, the corporations had to change a number of clauses in the contract that relate to vaccine licensing. According to the new terms, Valneva will finance 40% of the costs required to complete the project. Initially, the French manufacturer was to compensate 30% of the costs. At the same time, Pfizer undertakes to pay Valneva 22% of various payments related to licensing. They are increased up to $100 million. This amount will be broken down into several transactions, the volume of which depends on the volume of vaccine sales.
Pfizer sees the Lyme disease vaccine as an extremely promising area for its business. Sales of the drug are expected to be able to compensate for the company’s reduced profits due to lower sales of COVID-19 vaccines.
Recently Pfizer has focused its efforts on expanding business through the acquisition of pharmaceutical companies or investing in them. The U.S. corporation is interested in manufacturers that have reached the final stages of clinical development of certain drugs. Thus, Pfizer acquired Arena Pharmaceuticals and ReViral.

Tags: Global investment
0
Previous Post Indices are falling in the global market Next Post Bid and Ask: rules for using them to manage trades

You Might Also Like

Jio Platforms
Global investment
Indian telecommunications company Jio Platforms has received $9 billion in investments
21.01.2021
Apple Corporation
Global investment
Apple Corporation has increased its investments in the U.S. economy
16.01.2022
Pinduoduo
Global investment
Chinese marketplace Pinduoduo launches online store in the U.S.
27.11.2022
Xiaomi Corporation
Global investment
Xiaomi Corporation invested $400 million in Xpeng Motors
23.09.2020
Binance plans to buy banks
Global investment
Buying banks: cryptocurrency exchange Binance wants to expand its capabilities
14.01.2023
Caesars Entertainment
Global investment
Caesars Entertainment Company now owned by Eldorado Resorts
11.04.2021

Recent Posts

  • 1Noventiq
    Noventiq plans to float on the Nasdaq exchange
    29.05.2023
  • 2AI impact on transformation of the economy
    Is the world facing an imminent economic transformation?
    28.05.2023
  • 3Siemens digital bond
    Siemens digital bond: industrial giant offers to invest in blockchain-based securities
    27.05.2023
  • 4credit rating
    The Fitch agency left Latvia’s credit rating unchanged
    26.05.2023
  • 5Ernest Rady
    Ernest Rady: talented financier and successful businessman
    25.05.2023

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • The London Stock Exchange has announced the acquisition of Refinitiv

Social media

Editor's Picks

Chaslau Koniukh
Analytics

American bankers from JPMorgan and Goldman Sachs advise to invest in gold: review by Chaslau Koniukh.

Press Secretary
17.08.2020
Expert Chaslau Koniukh
Analytics

Chaslau Koniukh on the analysts’ opinion on the key stake size change soon

Press Secretary
18.06.2020
expert Chaslau Koniukh
Analytics

Chaslau Koniukh: Internet trade market in Russia may reach 2.78 trillion rubles.

Press Secretary
30.05.2020
Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh
Analytics

Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh

Press Secretary
16.05.2020

Latest Posts

Noventiq
Noventiq plans to float on the Nasdaq exchange
29.05.2023
AI impact on transformation of the economy
Is the world facing an imminent economic transformation?
28.05.2023
Siemens digital bond
Siemens digital bond: industrial giant offers to invest in blockchain-based securities
27.05.2023

Chaslau Koniukh

Expert Chaslau Koniukh

Chaslau Koniukh – an expert in marketing and project management, IT consulting, international investments, investor, financial analyst. A commodity trader, private consultant, entrepreneur, lecturer, author of several articles on the stock market.

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • The London Stock Exchange has announced the acquisition of Refinitiv
  • Inventor and businessman Isaac Singer: a success story
Expert Chaslau Koniukh
  • Facebook
  • Twitter
  • Instagram
  • Biography

Chaslau Koniukh – an expert in marketing and project management, international investments, financial analyst.

Social media

Menu

  • Biography
  • Companies and corporations
  • Global investment
  • Investors and Entrepreneurs
  • Economy
  • Market terminology
  • Stock Market
  • World exchanges
  • Tech and Marketing
  • Analytics